Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,497 | -12,487 | -6,433 | -29,919 | -23,659 |
| Accounts payable and accrued liabilities | -1,211 | -1,536 | -1,562 | 2,291 | 4,929 |
| Other Working Capital | -4,028 | -1,963 | -2,619 | -4,538 | -1,131 |
| Other Operating Activity | 2,939 | 2,778 | 2,420 | -1,379 | -4,581 |
| Operating Cash Flow | $-18,796 | $-13,207 | $-8,194 | $-33,544 | $-24,443 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 977 | 415 |
| Common Stock Issued | 18,962 | 10,439 | 241 | 23,195 | 6,552 |
| Other Financing Activity | -458 | -345 | -234 | -519 | -332 |
| Financing Cash Flow | $18,503 | $10,094 | $7 | $23,653 | $6,635 |
| Beginning Cash Position | 13,476 | 13,476 | 13,476 | 23,368 | 23,368 |
| End Cash Position | 13,183 | 10,364 | 5,289 | 13,476 | 5,559 |
| Net Cash Flow | $-293 | $-3,113 | $-8,187 | $-9,891 | $-17,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,796 | -13,207 | -8,194 | -33,544 | -24,443 |
| Free Cash Flow | -18,796 | -13,207 | -8,194 | -33,544 | -24,443 |